fixb protein, e coli has been researched along with acteoside in 1 studies
| Studies (fixb protein, e coli) | Trials (fixb protein, e coli) | Recent Studies (post-2010) (fixb protein, e coli) | Studies (acteoside) | Trials (acteoside) | Recent Studies (post-2010) (acteoside) |
|---|---|---|---|---|---|
| 19 | 0 | 5 | 514 | 11 | 341 |
| Protein | Taxonomy | fixb protein, e coli (IC50) | acteoside (IC50) |
|---|---|---|---|
| integrase, partial | Human immunodeficiency virus 1 | 1.407 | |
| lens epithelium-derived growth factor p75 | Homo sapiens (human) | 1.407 | |
| Protein kinase C alpha type | Rattus norvegicus (Norway rat) | 0.068 | |
| Protein kinase C delta type | Rattus norvegicus (Norway rat) | 0.068 | |
| Protein kinase C epsilon type | Rattus norvegicus (Norway rat) | 0.068 | |
| Protein kinase C zeta type | Rattus norvegicus (Norway rat) | 0.068 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 4.54 | |
| Protein kinase C alpha type | Homo sapiens (human) | 9.3 | |
| Protein kinase C gamma type | Rattus norvegicus (Norway rat) | 0.068 | |
| Protein kinase C beta type | Rattus norvegicus (Norway rat) | 0.068 | |
| Protein kinase C eta type | Rattus norvegicus (Norway rat) | 0.068 | |
| Integrase | Human immunodeficiency virus 1 | 7.8 | |
| Protein kinase C theta type | Rattus norvegicus (Norway rat) | 0.068 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kulkarni, SS; Singh, K | 1 |
1 review(s) available for fixb protein, e coli and acteoside
| Article | Year |
|---|---|
Small Carbohydrate Derivatives as Potent Antibiofilm Agents.
Topics: Anti-Bacterial Agents; Bacteria; Biofilms; Carbohydrates; Virulence | 2022 |